FDA Approves Veklury (remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment

FOSTER CITY, Calif.--(BUSINESS WIRE) August 24, 2023 -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury®...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news